Jaspreet Jain1, Kaustuv Nayak2, Neha Tanwar3, Rajni Gaind3, Bhupendra Gupta4, J S Shastri5, Raj K Bhatnagar6, Murali Krishna Kaja2,7, Anmol Chandele2, Sujatha Sunil1. 1. Vector Borne Diseases Group. 2. ICGEB-Emory Vaccine Center, International Center for Genetic Engineering and Biotechnology. 3. Department of Microbiology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India. 4. Medicine, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi. 5. Department of Microbiology, BYL Nair Ch. Hospital & T. N. Medical College, Mumbai. 6. International Center for Genetic Engineering and Biotechnology, New Delhi, India. 7. Emory Vaccine Center, Emory University School of Medicine, Atlanta, Georgia.
Abstract
Background: Chikungunya fever (CHIK) is a major public health concern in India. Characterized by acute fever with joint pain and swelling, most patients recover from this self-limiting illness in 7-10 days, with cessation of joint pain post-acute episode. However, in some patients, joint pain persists, lasting for months or even years. The precise correlates to the chronic phase of this debilitating illness and/or this remarkable heterogeneity in disease manifestation are poorly understood. Methods: We evaluated 572 chikungunya patients from India who were recruited on the basis of positive real-time polymerase chain reaction and/or CHIK virus immunoglobulin (IgM) after receiving consent. Arthralgic conditions were monitored using visual analog score (VAS) 12 weeks after onset of fever in 130 patients. Initial viral load, IgG, and initial neutralization response were assayed and correlated with clinical and VAS information in 40 patients. Results: Our extensive screening revealed that patients with higher initial viral loads during the acute phase of illness had poor prognosis at the post-acute phase with more restricted joint movement and higher VAS. Additionally, patients who showed early seroconversion to neutralizing IgG responses had better prognosis, as many of these patients did not manifest restricted joint movements at the post-acute phase. Conclusions: Our study sheds light on chikungunya disease with respect to disease progression and assesses clinical, virological, and serological parameters of chikungunya disease severity. Importantly, it reveals that initial high viral load and neutralizing IgG response may function in a seemingly contrasting manner to negatively or positively dictate disease outcome.
Background: Chikungunya fever (CHIK) is a major public health concern in India. Characterized by acute fever with joint pain and swelling, most patients recover from this self-limiting illness in 7-10 days, with cessation of joint pain post-acute episode. However, in some patients, joint pain persists, lasting for months or even years. The precise correlates to the chronic phase of this debilitating illness and/or this remarkable heterogeneity in disease manifestation are poorly understood. Methods: We evaluated 572 chikungunya patients from India who were recruited on the basis of positive real-time polymerase chain reaction and/or CHIK virus immunoglobulin (IgM) after receiving consent. Arthralgic conditions were monitored using visual analog score (VAS) 12 weeks after onset of fever in 130 patients. Initial viral load, IgG, and initial neutralization response were assayed and correlated with clinical and VAS information in 40 patients. Results: Our extensive screening revealed that patients with higher initial viral loads during the acute phase of illness had poor prognosis at the post-acute phase with more restricted joint movement and higher VAS. Additionally, patients who showed early seroconversion to neutralizing IgG responses had better prognosis, as many of these patients did not manifest restricted joint movements at the post-acute phase. Conclusions: Our study sheds light on chikungunya disease with respect to disease progression and assesses clinical, virological, and serological parameters of chikungunya disease severity. Importantly, it reveals that initial high viral load and neutralizing IgG response may function in a seemingly contrasting manner to negatively or positively dictate disease outcome.
Authors: Ralph Huits; Jaclyn De Kort; Riemsdijk Van Den Berg; Luis Chong; Achilleas Tsoumanis; Kaat Eggermont; Koen Bartholomeeusen; Kevin K Ariën; Jan Jacobs; Marjan Van Esbroeck; Emmanuel Bottieau; Lieselotte Cnops Journal: PLoS One Date: 2018-04-30 Impact factor: 3.240